GENELUX director granted RSUs and stock options

GENELUX Corp director James L. Tyree reported equity awards from the company.

Rhea-AI Filing Summary

GENELUX Corp director James L. Tyree reported equity awards from the company. He received 28,409 shares of common stock in the form of restricted stock units, which each convert into one share of common stock when they vest. After this grant, he directly holds 96,483 shares of common stock.

Tyree was also granted stock options for 31,566 shares of common stock at an exercise price of $3.03 per share, expiring on June 15, 2036. Both the RSUs and the options vest on the earlier of the one-year anniversary of the June 16, 2026 grant date or the company’s next annual meeting of stockholders.

Insider Trade Summary

Grant/Award: 59,975 shares

Grant/Award 2 txns

Insider Tyree James L

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy)	31,566	$0.00	$0.00
Grant/Award	Common Stock	28,409	$0.00	$0.00

Holdings After Transaction: Stock Option (Right to Buy) — 31,566 contracts (Direct); Common Stock — 96,483 shares (Direct)

Footnotes (2)

1. F1. Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of common stock upon vesting. The RSUs will vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Issuer's next annual meeting of stockholders.
2. F2. The shares subject to the option will vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Issuer's next annual meeting of stockholders.

Key Figures

RSU grant: 28,409 shares Common shares held: 96,483 shares Stock options granted: 31,566 options +2 more

5 metrics

RSU grant 28,409 shares Restricted stock units granted June 16, 2026

Common shares held 96,483 shares Direct common stock holding after transaction

Stock options granted 31,566 options Stock Option (Right to Buy) grant on common stock

Option exercise price $3.03 per share Exercise price for 31,566 stock options

Option expiration June 15, 2036 Expiration date of granted stock options

Key Terms

restricted stock units ("RSUs"), 2022 Equity Incentive Plan, Stock Option (Right to Buy), annual meeting of stockholders

4 terms

restricted stock units ("RSUs") financial

"Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2022 Equity Incentive Plan."

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

2022 Equity Incentive Plan financial

"RSUs granted pursuant to the Issuer's 2022 Equity Incentive Plan."

Stock Option (Right to Buy) financial

"Security title listed as Stock Option (Right to Buy)."

annual meeting of stockholders financial

"Vest upon the earlier of the one-year anniversary or the Issuer's next annual meeting of stockholders."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did GENELUX Corp (GNLX) report for James L. Tyree?

GENELUX Corp reported that director James L. Tyree received equity awards, including restricted stock units and stock options, as compensation. These awards increase his direct holdings in the company and are structured to vest over time based on service through the next annual meeting.

How many GENELUX (GNLX) shares does James L. Tyree hold after this Form 4?

After the reported transaction, James L. Tyree directly holds 96,483 shares of GENELUX common stock. This figure reflects his position following the grant of 28,409 restricted stock units that represent future delivery of common shares upon vesting, subject to the stated vesting conditions.

What restricted stock unit grant did GENELUX (GNLX) give to James L. Tyree?

GENELUX granted James L. Tyree 28,409 restricted stock units under its 2022 Equity Incentive Plan. Each RSU represents the right to receive one share of common stock upon vesting, which occurs on the earlier of one year from grant or the next annual stockholder meeting.

What stock options did GENELUX (GNLX) award to James L. Tyree and at what price?

James L. Tyree received stock options for 31,566 shares of GENELUX common stock at an exercise price of $3.03 per share. These options vest on the earlier of one year from the grant date or the next annual meeting and expire on June 15, 2036.

When do James L. Tyree’s GENELUX (GNLX) RSUs and options vest?

Both the restricted stock units and stock options granted to James L. Tyree vest on the earlier of two dates: the one-year anniversary of the June 16, 2026 grant date or the date of GENELUX’s next annual meeting of stockholders, aligning incentives with board service duration.

Are James L. Tyree’s GENELUX (GNLX) equity awards part of a compensation plan?

Yes. The restricted stock units granted to James L. Tyree were issued under GENELUX’s 2022 Equity Incentive Plan. This plan provides equity-based compensation, such as RSUs and stock options, to align directors’ and executives’ interests with company performance and long-term shareholder value.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/18/2026 - 07:05 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Tyree James L

(Last) (First) (Middle)

C/O GENELUX CORPORATION

2625 TOWNSGATE ROAD, SUITE 230

(Street)

WESTLAKE VILLAGE CALIFORNIA 91361

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
GENELUX Corp [ GNLX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/16/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/16/2026		A(1)		28,409	A	$0	96,483	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$3.03	06/16/2026		A		31,566		(2)	06/15/2036	Common stock	31,566	$0	31,566	D

Explanation of Responses:

1. Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of common stock upon vesting. The RSUs will vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Issuer's next annual meeting of stockholders.

2. The shares subject to the option will vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Issuer's next annual meeting of stockholders.

	/s/ Thomas Zindrick, Attorney-in-Fact	06/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)